Patents by Inventor Janne Komi

Janne Komi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060293294
    Abstract: This invention relates to a method for the treatment or prevention of androgen deficiency in a male individual by administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture, metabolite or a pharmaceutically acceptable salt thereof. Furthermore, the invention concerns methods for the treatment or prevention of diseases or disorders caused by androgen deficiency.
    Type: Application
    Filed: July 18, 2005
    Publication date: December 28, 2006
    Applicant: HORMOS MEDICAL CORPORATION
    Inventors: Taru Blom, Janne Komi, Risto Lammintausta
  • Patent number: 7008666
    Abstract: The invention relates to a method of inhibiting myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan, where said lignan is enterolactone. The invention is further directed to a method inhibiting myeloperoxidase activity or oxidative burst of macrophages in an individual by administering to the individual an effective amount of a lignan where said lignan is enterolactone or hydroxymatairesinol or a mixture. Finally, the invention is directed to a method of inhibiting oxidative burst or myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan which is hydroxymatairesinol.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: March 7, 2006
    Assignee: Hormos Nutraceutical Oy Ltd.
    Inventors: Markku Ahotupa, John Eriksson, Lauri Kangas, Mikko Unkila, Janne Komi, Merja Perälä, Helena Korte
  • Publication number: 20030100514
    Abstract: This invention relates to a method of inhibiting the overactivity of phagocytes or lymphocytes in an individual by administering to said individual an effective amount of a lignan, wherein
    Type: Application
    Filed: November 26, 2001
    Publication date: May 29, 2003
    Inventors: Markku Ahotupa, John Eriksson, Lauri Kangas, Mikko Unkila, Janne Komi, Merja Perala, Helena Korte